GleamWall
中文EN

MNKD MANNKIND CORP

Pharmaceutical Preparations · Nasdaq · SEC CIK 899460 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY31.7%
TTM net income YoY-356.0%
TTM EPS YoY-340.0%
Revenue 3-yr CAGR32.8%
Net income 3-yr CAGR—

Margins

Gross margin88.6%
Operating margin-2.9%
Net margin-18.1%
FCF margin-19.0%
EBITDA margin1.1%

Returns

ROE—
ROA-12.3%
ROIC (approx.)-10.5%
Asset turnover0.68x

Leverage & solvency

Liabilities / assets105.2%
Debt / equity—
Current ratio2.22x
Interest coverage-0.34x

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-1.4%
Payout ratio—
Capex / revenue2.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$101.87M$109.37M$90.17M$111.95M$82.13M$76.53M$78.35M$76.78M
Cost of revenue$11.21M$14.41M$7.51M$13.93M$4.50M$4.61M$3.77M$4.81M
Gross profit$90.66M$94.97M$82.66M$98.03M$77.63M$71.92M$74.59M$71.97M
R&D expense$14.36M$18.00M$17.23M$27.59M$14.06M$13.68M$11.02M$11.14M
SG&A expense$61.41M$58.30M$54.09M$58.41M$29.09M$31.62M$25.01M$60.16M
Operating income-$2.18M-$350,000-$1.67M-$7.69M$18.90M$5.30M$22.29M$26.50M
Interest expense$7.64M$11.89M$7.48M$7.54M$1.36M$285,000$4.64M$1.56M
Pretax income-$23.17M-$19.14M-$16.37M-$20.93M$7.78M$940,000$13.62M$8.45M
Income tax$51,000-$106,000$253,000-$4.98M-$204,000$272,000$459,000$1.02M
Net income-$23.22M-$19.03M-$16.62M-$15.95M$7.99M$668,000$13.16M$7.42M
EBITDA-$112,000$1.68M$4.71M-$1.66M$20.91M$7.34M$24.40M$28.66M
EPS (basic)-0.07-0.06-0.05—0.030.000.04—
EPS (diluted)-0.07-0.06-0.05—0.030.000.04—
Weighted avg. shares (diluted)320.18M309.19M308.27M—311.64M311.48M320.90M—
Balance sheet
Cash & equivalents$41.28M$52.93M$52.83M$74.88M$127.39M$57.01M$47.31M$46.34M
Short-term investments$55.33M$58.20M$81.03M$96.46M$132.64M$121.98M$134.23M$150.92M
Receivables$41.03M$43.21M$28.14M$38.37M$17.38M$27.14M$28.90M$11.80M
Inventory$48.47M$44.42M$49.17M$35.31M$26.97M$28.49M$28.89M$27.89M
Current assets$240.48M$245.71M$251.16M$291.58M$358.84M$279.03M$273.74M$268.31M
PP&E, net$86.37M$85.16M$82.55M$82.42M$82.65M$82.97M$83.78M$85.36M
Goodwill$67.59M$67.59M$67.59M$67.59M$1.93M$1.93M$1.93M$1.93M
Intangibles$4.93M$4.98M$5.02M$5.07M$5.12M$5.17M$5.22M$5.26M
Total assets$722.62M$732.30M$744.40M$792.18M$494.64M$411.70M$410.14M$393.84M
Current liabilities$108.52M$142.90M$134.56M$171.03M$109.13M$111.83M$115.94M$81.84M
Long-term debt$319.45M$319.08M$318.72M$354.64M$109.65M$36.17M$36.11M$36.05M
Total debt$319.45M$319.08M$318.72M$354.64M$109.65M$36.17M$36.11M$36.05M
Total liabilities$759.88M$799.50M$803.60M$843.20M$539.19M$466.74M$468.76M$472.66M
Shareholders' equity-$37.27M-$67.20M-$59.20M-$51.02M-$44.55M-$55.04M-$58.62M-$78.82M
Net debt$278.17M$266.16M$265.89M$279.76M-$17.74M-$20.84M-$11.20M-$10.29M
Shares outstanding321.63M309.91M308.91M307.83M307.03M306.33M303.92M302.96M
Cash flow statement
Operating cash flow-$34.55M-$18.37M-$5.37M-$7.96M$23.64M$8.95M-$6.38M$22.64M
Capital expenditure$3.21M$5.08M$1.88M$1.99M$1.12M$1.12M$330,000$2.90M
Free cash flow-$37.76M-$23.45M-$7.25M-$9.95M$22.52M$7.83M-$6.71M$19.75M
Investing cash flow-$252,000$17.91M$18.73M-$291.96M-$25.06M$6.26M$5.96M$48.22M
Financing cash flow$23.15M$559,000-$35.41M$247.41M$71.81M-$5.51M$1.39M-$86.90M
Depreciation & amortization$2.07M$2.03M$6.38M$6.03M$2.01M$2.04M$2.11M$2.16M
Stock-based compensation$6.44M$10.23M$6.46M$6.97M$4.32M$7.52M$5.38M$5.82M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.